Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,309 | -54,228 | -58,590 | -63,057 | -46,277 |
| Depreciation Amortization | 593 | 621 | 596 | 587 | 637 |
| Accounts receivable | -904 | 392 | -722 | 37,792 | -37,624 |
| Accounts payable and accrued liabilities | 499 | -473 | 1,790 | 3,307 | 1,673 |
| Other Working Capital | -33,023 | -15,244 | -9,600 | 53,416 | 23,956 |
| Other Operating Activity | 10,504 | 19,470 | 10,301 | -22,687 | 43,799 |
| Operating Cash Flow | $-67,640 | $-49,462 | $-56,225 | $9,359 | $-13,836 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 117,412 | 45,121 | N/A | N/A | N/A |
| PPE Investments | -211 | -56 | -173 | -1,803 | -652 |
| Purchase Of Investment | -139,167 | -25,771 | -19,945 | 13,751 | 12,840 |
| Purchase Sale Intangibles | N/A | N/A | -371 | -32 | -4 |
| Other Investing Activity | 0 | 0 | -343 | -18 | 162 |
| Investing Cash Flow | $-21,966 | $19,294 | $-20,461 | $11,930 | $12,350 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 142,087 | 31,937 | 53,482 | 42,521 | 20,326 |
| Other Financing Activity | 0 | 0 | -235 | -290 | -516 |
| Financing Cash Flow | $142,087 | $31,937 | $53,247 | $42,231 | $19,810 |
| Exchange Rate Effect | 60 | 749 | 282 | -144 | -431 |
| Beginning Cash Position | 68,789 | 66,271 | 90,958 | 37,745 | 17,353 |
| End Cash Position | 121,330 | 68,789 | 67,802 | 101,121 | 35,245 |
| Net Cash Flow | $52,541 | $2,518 | $-23,156 | $63,376 | $17,891 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,640 | -49,462 | -56,225 | 9,359 | -13,836 |
| Capital Expenditure | -211 | -56 | -173 | -1,803 | -656 |
| Free Cash Flow | -67,851 | -49,518 | -56,398 | 7,556 | -14,493 |